The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Assist. Prof. Matthew Davids | ASH 2017 | iFCR incorporated into armamentarium for treatment of CLL

Jan 3, 2018

59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA
Assistant Professor Matthew Davids
Dana-Farber/Harvard Cancer Center, Boston, US

Interview Topic: How do you see iFCR being incorporated into the armamentarium for the treatment of CLL?

Assist. Prof. Matthew Davids | ASH 2017 | iFCR incorporated into armamentarium for treatment of CLL